Mowel (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mowel, is an antimetabolite immunosuppressant presented as an oral tablet for oral use. It is employed to prevent organ transplant rejection, treat lupus nephritis, and manage selected autoimmune diseases in adult patients.

GNH USA supplies Mowel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide. The company adheres to EU quality standards and provides reliable sourcing for clinical programs.

Mowel, an antimetabolite immunosuppressant, is used in conditions where suppression of the immune response is required.

- Organ transplant rejection: helps prevent graft rejection by inhibiting lymphocyte proliferation. - Lupus nephritis: reduces renal inflammation and proteinuria in patients with systemic lupus erythematosus. - Certain autoimmune diseases: controls disease activity in conditions such as vasculitis and dermatomyositis.

Mycophenolate mofetil may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Vomiting - Abdominal pain - Headache - Upper respiratory tract infections

Serious or Rare Side Effects: - Bone marrow suppression (leukopenia, anemia, thrombocytopenia) - Severe or opportunistic infections - Increased risk of malignancies - Hepatic injury (elevated transaminases, hepatitis) - Progressive multifocal leukoencephalopathy - Teratogenic effects leading to fetal harm

When prescribing Mowel, clinicians should observe several safety considerations.

- Monitor blood counts: perform regular complete blood count assessments. - Monitor liver function: check hepatic enzymes periodically. - Assess renal function: adjust dosing in patients with impaired clearance. - Avoid use in pregnancy: drug is contraindicated due to teratogenic risk. - Counsel on contraception: ensure effective birth control for women of child‑bearing potential. - Store at ambient temperature: keep in the original pack, protect from moisture.

Mycophenolate mofetil can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption. - Cyclosporine: increases mycophenolate exposure and toxicity. - Tacrolimus: may potentiate immunosuppression. - Rifampin: induces metabolism, lowering drug levels. - Live vaccines: heightened risk of infection.

Moderate Interactions (Monitor Closely): - Azathioprine: additive bone‑marrow suppression. - Warfarin: may enhance anticoagulant effect. - Inactivated vaccines: monitor immune response. - NSAIDs: increase risk of renal impairment. - Cholestyramine: may bind drug and reduce absorption.